Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
Growth of lymphoblastoid cells (B95-8, Raji) is not inhibited by the presence of 0.4 mM phosphonoacetic acid. The synthesis of Epstein-Barr virus (EBV) in the producer line B95-8 is completely inhibited, as shown by the total inhibition of viral capsid antigen synthesis. Early viral antigens are made normally in the presence of phosphonoacetic acid, but EBV DNA synthesis is blocked in cells entering the productive cycle. Nonproducer cells in the population replicate the resident EBV DNA by a mechanism that is resistant to phosphonoacetic acid. These results are consistant with the hypotheses that EBV DNA is replicated by two mechanisms, one in the noninduced cell and a different mechanism in the producer cell, and that prior replication of EBV DNA, probably by the second mode, is a prerequisite for late gene expression.
D000085:Acetates / Q000494:pharmacology*; D000956:Antigens, Viral; D002460:Cell Line; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004854:Herpesvirus 4, Human / Q000254:growth & development / Q000276:immunology / Q000378:metabolism*; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
D000085:Acetates; D000956:Antigens, Viral; D004279:DNA, Viral; D004791:Enzyme Inhibitors; D009943:Organophosphorus Compounds